Briacell Therapeutics Corp (BCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 07/31
01-2023 | 10-2022 | 07-2022 | 04-2022 | 01-2022 | |
Operating Expenses | 4,486 | 5,403 | 5,234 | 4,123 | 3,647 |
Operating Income | -4,486 | -5,403 | -5,234 | -4,123 | -3,647 |
Interest Expense | 7,395 | 0 | 0 | 0 | 0 |
Other Income | 0 | 4,297 | 4,784 | -5,892 | 14,807 |
Pre-tax Income | -11,882 | -1,107 | -450 | -10,016 | 11,161 |
Net Income Continuous | -11,882 | -1,107 | -450 | -10,016 | 11,161 |
Net Income | $-11,882 | $-1,107 | $-450 | $-10,016 | $11,161 |
EPS Basic Total Ops | -0.77 | -0.07 | 0.02 | -0.65 | 0.71 |
EPS Basic Continuous Ops | -0.77 | -0.07 | 0.02 | -0.65 | 0.71 |
EPS Diluted Total Ops | -0.77 | -0.07 | 0.69 | -0.65 | 0.04 |
EPS Diluted Continuous Ops | -0.77 | -0.07 | 0.12 | -0.65 | 0.61 |
EPS Diluted Before Non-Recurring Items | -0.77 | -0.07 | -1.01 | N/A | N/A |
EBITDA(a) | $-4,483 | $-5,399 | $-5,230 | $-4,119 | $-3,643 |